These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis. Lim EH; Danthi N; Bednarski M; Li KC Nanomedicine; 2005 Jun; 1(2):110-4. PubMed ID: 17292065 [No Abstract] [Full Text] [Related]
4. Quantum dots for tumor-targeted drug delivery and cell imaging. Misra RD Nanomedicine (Lond); 2008 Jun; 3(3):271-4. PubMed ID: 18510421 [No Abstract] [Full Text] [Related]
5. [Molecular imaging in cancer therapy]. Weber WA Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):810-7. PubMed ID: 20700780 [TBL] [Abstract][Full Text] [Related]
6. Targeting tumors with nanobodies for cancer imaging and therapy. Oliveira S; Heukers R; Sornkom J; Kok RJ; van Bergen En Henegouwen PM J Control Release; 2013 Dec; 172(3):607-17. PubMed ID: 24035975 [TBL] [Abstract][Full Text] [Related]
7. Combined molecular targeting for cancer therapy: a new paradigm in need of molecular imaging. DeNardo SJ J Nucl Med; 2006 Jan; 47(1):4-5. PubMed ID: 16391180 [No Abstract] [Full Text] [Related]
8. Molecular imaging and therapy -- a programme based on the development of new biomolecules. Haberkorn U; Eisenhut M Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1354-9. PubMed ID: 16133375 [No Abstract] [Full Text] [Related]
9. [Molecular diagnosis and therapy in oncology]. Baretton G; Grabbe S; Keilholz U; Sauter G Onkologie; 2011; 34 Suppl 2():5-9. PubMed ID: 21447986 [No Abstract] [Full Text] [Related]
10. [Target molecules of molecular target therapy of cancer]. Uehara Y Nihon Rinsho; 2004 Jul; 62(7):1206-8. PubMed ID: 15283134 [No Abstract] [Full Text] [Related]
13. Targeted therapies: aiming for the bull's-eye. Gaguski ME ONS Connect; 2007 Jul; 22(7):8-12. PubMed ID: 17694778 [No Abstract] [Full Text] [Related]
14. Targeted cancer. These "smart weapons" hit cancer in novel ways. Held-Warmkessel J Nursing; 2008 Sep; 38(9):26-32. PubMed ID: 18719487 [TBL] [Abstract][Full Text] [Related]
15. Antibody-drug conjugates for cancer: poised to deliver? Hughes B Nat Rev Drug Discov; 2010 Sep; 9(9):665-7. PubMed ID: 20811367 [No Abstract] [Full Text] [Related]
16. [Targeted therapy of neoplasms and pharmacopathology]. Zhu XZ Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):468-70. PubMed ID: 16383287 [No Abstract] [Full Text] [Related]
17. The direct route may not be the best way to home. Sharkey RM J Nucl Med; 2005 Mar; 46(3):391-4. PubMed ID: 15750148 [No Abstract] [Full Text] [Related]
18. Targeted cancer therapeutics: the heartbreak of success. Mann DL Nat Med; 2006 Aug; 12(8):881-2. PubMed ID: 16892027 [No Abstract] [Full Text] [Related]
19. [Current status and prospect of neoplasm targeted therapy]. Wang Y; Sun Y Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):638-40. PubMed ID: 16438880 [No Abstract] [Full Text] [Related]
20. Strategies for molecular imaging of epidermal growth factor receptor tyrosine kinase in cancer. Mishani E; Hagooly A J Nucl Med; 2009 Aug; 50(8):1199-202. PubMed ID: 19617320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]